RxDoctor Payments Data

Majed Jandali, MD

Surgery · Pleasant Prairie, WINPI 1679635171

Payments from drug & device makers

What this record shows

This record is dominated by education: $49,500 of the $62,539 with a category attached, or 79.2%. Intuitive Surgical accounts for 89.6% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $25,024 and has fallen 93.5% since, to $1,631 in 2025. Among surgery clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$62,539in general payments, 2019–2025

Across 134 payments — averaging $466.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$56K
  • Medtronic$3K
  • W. L. Gore & Associates, Inc.$2K
  • Johnson & Johnson$253
  • Straumann USA LLC$138
  • Takeda Pharmaceuticals U.S.A., Inc.$89
  • plus $431 from 13 others

What the payments were for

  • Travel & lodging$8,35613%
  • Food & beverage$4,6837%
  • Education$49,50079%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$62,539 in reported general payments places this provider in the 95th percentile of 499 surgery providers in Wisconsin.

See all surgery providers in Wisconsin

Medicare billing

Part B allowed, 2024
$351,134
Medicare patients
409
Services billed
1,481

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide13$15,142
KonvomepOmeprazole/Sodium Bicarbonate11$3,787
Colestipol Hcl17$1,890
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen176$844
Omeprazole46$509
ErythromycinErythromycin Base11$507
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl30$498
Ondansetron OdtOndansetron13$163
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl12$124
Ondansetron Hcl12$94
Neomycin Sulfate15$80
Metoclopramide Hcl52$45
Ibuprofen11$32
Tramadol Hcl12$14

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$37$15,14213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 499 surgery providers in Wisconsin.

Other surgery in Pleasant Prairie

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →